OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Look to the Past - What Has Had the Biggest Impact on Lipids in the Last Four Decades? A Personal Perspective
Maciej Banach, Stanisław Surma
Archives of Medical Science (2023)
Open Access | Times Cited: 17
Maciej Banach, Stanisław Surma
Archives of Medical Science (2023)
Open Access | Times Cited: 17
Showing 17 citing articles:
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
Maciej Banach, Stanisław Surma, Peter P. Tóth
Archives of Medical Science (2023)
Open Access | Times Cited: 31
Maciej Banach, Stanisław Surma, Peter P. Tóth
Archives of Medical Science (2023)
Open Access | Times Cited: 31
Dyslipidaemia management in pregnant patients: a 2024 update
Joanna Lewek, Agata Bielecka‐Dąbrowa, Peter P. Tóth, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Joanna Lewek, Agata Bielecka‐Dąbrowa, Peter P. Tóth, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 11
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Drugs (2024)
Open Access | Times Cited: 9
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Drugs (2024)
Open Access | Times Cited: 9
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Current Atherosclerosis Reports (2024)
Open Access | Times Cited: 6
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Current Atherosclerosis Reports (2024)
Open Access | Times Cited: 6
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia
Qiannan Fang, Xinyu Lu, Yuanqiang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101614-101614
Open Access | Times Cited: 5
Qiannan Fang, Xinyu Lu, Yuanqiang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101614-101614
Open Access | Times Cited: 5
Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis
Maciej Banach, Vikash Jaiswal, Song Peng Ang, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Maciej Banach, Vikash Jaiswal, Song Peng Ang, et al.
Mayo Clinic Proceedings (2025)
Closed Access
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Cardiosomatics (2025)
Open Access
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Cardiosomatics (2025)
Open Access
Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Nutrients (2023) Vol. 15, Iss. 11, pp. 2629-2629
Open Access | Times Cited: 7
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Nutrients (2023) Vol. 15, Iss. 11, pp. 2629-2629
Open Access | Times Cited: 7
Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association
Maciej Banach, Stanisław Surma, Agnieszka Kapłon‐Cieślicka, et al.
Archives of Medical Science (2023) Vol. 20, Iss. 1, pp. 28-42
Open Access | Times Cited: 5
Maciej Banach, Stanisław Surma, Agnieszka Kapłon‐Cieślicka, et al.
Archives of Medical Science (2023) Vol. 20, Iss. 1, pp. 28-42
Open Access | Times Cited: 5
2024 Update on Postmarketing Nutrivigilance Safety Profile: A Line of Dietary Food Supplements Containing Red Yeast Rice for Dyslipidemia.
Maciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Archives of Medical Science (2024)
Open Access | Times Cited: 1
Maciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Archives of Medical Science (2024)
Open Access | Times Cited: 1
Efficacy of statin therapy in reducing epicardial adipose tissue: a systematic review and meta-analysis
Tannaz Jamialahmadi, Luis E. Simental‐Mendía, Ali H. Eid, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 3, pp. 997-1001
Open Access | Times Cited: 1
Tannaz Jamialahmadi, Luis E. Simental‐Mendía, Ali H. Eid, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 3, pp. 997-1001
Open Access | Times Cited: 1
Summary of 2023 and the biggest challenges for the “Archives of Medical Science” on its 20th Anniversary
Maciej Banach
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 1-7
Open Access
Maciej Banach
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 1-7
Open Access
Impact of Rapamycin on Longevity: Updated Insights
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, et al.
Archives of Medical Science (2024)
Open Access
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, et al.
Archives of Medical Science (2024)
Open Access
Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies
Richard Webb, Maha Al‐Asmakh, Maciej Banach, et al.
Drug Discovery Today (2024), pp. 104186-104186
Closed Access
Richard Webb, Maha Al‐Asmakh, Maciej Banach, et al.
Drug Discovery Today (2024), pp. 104186-104186
Closed Access
Celebrating the 90th birthday of the scientist who discovered statins: Akira Endō
Stanisław Surma, Dimitri P. Mikhailidis, Maciej Banach
European Heart Journal (2023) Vol. 45, Iss. 9, pp. 647-650
Open Access | Times Cited: 1
Stanisław Surma, Dimitri P. Mikhailidis, Maciej Banach
European Heart Journal (2023) Vol. 45, Iss. 9, pp. 647-650
Open Access | Times Cited: 1
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS) - study design and methodology.
Maciej Banach, Martyna Fronczek, Tadeusz Osadnik, et al.
Archives of Medical Science (2024)
Open Access
Maciej Banach, Martyna Fronczek, Tadeusz Osadnik, et al.
Archives of Medical Science (2024)
Open Access
Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 11, pp. 6148-6148
Open Access
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 11, pp. 6148-6148
Open Access
